Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method.
- Published in:
- Drug Safety, 2022, v. 45, n. 4, p. 389, doi. 10.1007/s40264-022-01173-4
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2022 AND VI 45 AND IP 4
Results: 10
1
2
Correction to: A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
3
Postoperative Respiratory Events in Surgical Patients Exposed to Opioid Analgesic Shortages Compared to Fully Matched Patients Non-exposed to Shortages.
- Published in:
- Drug Safety, 2022, v. 45, n. 4, p. 359, doi. 10.1007/s40264-022-01171-6
- By:
- Publication type:
- Article
4
Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding.
- Published in:
- Drug Safety, 2022, v. 45, n. 4, p. 345, doi. 10.1007/s40264-022-01168-1
- By:
- Publication type:
- Article
5
New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the Evidence.
- Published in:
- Drug Safety, 2022, v. 45, n. 4, p. 305, doi. 10.1007/s40264-022-01152-9
- By:
- Publication type:
- Article
6
Correction to: Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
7
A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project.
- Published in:
- Drug Safety, 2022, v. 45, n. 4, p. 333, doi. 10.1007/s40264-022-01154-7
- By:
- Publication type:
- Article
8
Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
- Published in:
- Drug Safety, 2022, v. 45, n. 4, p. 319, doi. 10.1007/s40264-022-01151-w
- By:
- Publication type:
- Article
9
Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach.
- Published in:
- Drug Safety, 2022, v. 45, n. 4, p. 369, doi. 10.1007/s40264-022-01149-4
- By:
- Publication type:
- Article
10
Intracranial Hemorrhage Following Anticoagulant Treatment in Denmark: Spontaneous Adverse Drug Reaction Reports Versus Real-World Data.
- Published in:
- Drug Safety, 2022, v. 45, n. 4, p. 379, doi. 10.1007/s40264-022-01147-6
- By:
- Publication type:
- Article